Sphingosine 1-phosphate receptor-3 enhances pro-inflammatory activity in human monocytes

JinChao Hou,XiangMing Fang
DOI: https://doi.org/10.4049/jimmunol.190.supp.203.9
2013-01-01
Abstract:Abstract Objective: Sphingosine 1-phosphate receptor-3(S1P3) is a G protein-coupled receptor constitutively expressed in human monocytes and plays important roles in the innate immune response. This study is aimed to determine the level of S1P3 in septic patients and explore its role in signaling pro-inflammation activity. Method: Patients with sepsis, non-sepsis and trauma were enrolled, and S1P3 levels in monocytes were determined by real-time PCR and flow cytometry. The S1P3 levels were also measured in primary monocytes from healthy donors and THP-1 cell line after 100 ng/ml LPS or 10 ng/ml TNF-α stimulation for 24 hours. Furthermore, the S1P3 receptor was interfered by agonist (GPS-725.017), antagonist (suramin) or S1P3-specific shRNA to explore the relative intracellular signaling pathway. Results: The levels of S1P3 in septic patients were higher than those in non-septic controls and traumatic patients. LPS or TNF-α stimulation upregulated both mRNA and protein levels of S1P3. Furthermore, the LPS-induced MAPK activity and NF-κB activity in THP-1 cells could be enhanced by GPS-725.017 while reduced by suramin. Knock-down of S1P3 expression in THP-1 monocytes also reduced LPS-induced IL-1β and TNF-α production. Conclusion: The levels of S1P3 in human monocytes could be up-regulated by LPS and TNF-α. S1P3 could enhance LPS-induced pro-inflammatory activity, which involved MAPK and NF-κB pathways.
What problem does this paper attempt to address?